Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Ristia Bintang Mahkotasejati Tbk. (RBMS) vs Organon Pharma Indonesia Tbk. (SCPI)

Ristia Bintang Mahkotasejati Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Ristia Bintang Mahkotasejati Tbk. dan Organon Pharma Indonesia Tbk.: Ristia Bintang Mahkotasejati Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 162,03 M, volume 24 jam 15,21 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ristia Bintang Mahkotasejati Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

RBMSSCPI
Kapitalisasi Pasar
162,03 M104,4 M
Volume
15,21 jt
Lot
152,08 rb
Perputaran
946,82 jt
Harga Rata-rata
62,26
Nilai Transaksi
946,82 jt
Harga Ekuilibrium Indikatif
63
Volume Ekuilibrium Indikatif
5,97 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

RBMS
Lihat detail
SCPI
Lihat detail

Tentang Ristia Bintang Mahkotasejati Tbk.

PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.

Selengkapnya di halaman RBMS

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI